SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

DiaMedica Therapeutics Q1 EPS $(0.190) Up From $(0.270) YoY

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.190) per share. This is a 29.63 percent increase over losses of $(0.270) per share from the same period last year.

Benzinga · 05/13/2020 20:42

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.190) per share. This is a 29.63 percent increase over losses of $(0.270) per share from the same period last year.